Pneumococcal Bacteremia in Febrile Infants Presenting to the Emergency Department Before and After the Introduction of the Heptavalent Pneumococcal Vaccine

Annals of Emergency Medicine

Volumn 49, Issue 6, 2007, Pages 772-777

  Carstairs, Keri L ^a   Tanen, David A ^a   Johnson, Andrew S ^a   Kailes, Steven B ^a   Riffenburgh, Robert H ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PNEUMOCOCCUS VACCINE;

ACUTE GASTROENTERITIS; ARTICLE; BACTEREMIA; BLOOD CULTURE; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; ELECTRONIC MEDICAL RECORD; FEMALE; FEVER; HUMAN; INFANT; INFORMATION PROCESSING; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBSERVATIONAL STUDY; PNEUMOCOCCAL BACTEREMIA; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TERTIARY HEALTH CARE; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VACCINATION;

BACTEREMIA; CHILD, PRESCHOOL; FEMALE; FEVER; HUMANS; IMMUNIZATION; INFANT; INFANT, NEWBORN; MALE; MENINGOCOCCAL VACCINES; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES;

EID: 34248596328     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2006.10.026     Document Type: Article

References (22)

1. Slater M., and Krug S.E. Evaluation of the infant with fever source: an evidence based approach. Emerg Med Clin North Am 17 (1999) 97-126
2. Lee G.M., and Harper M.B. Risk of bacteremia for febrile young children in the post-Haemophilus influenzae type b era. Arch Pediatr Adolesc Med 152 (1998) 624-628
3. American College of Emergency Physicians. ACEP clinical policy for children younger than three years presenting to the emergency department with fever. Ann Emerg Med 42 (2003) 530-545
4. Baraff L.J. Clinical policy for children younger than three years presenting to the emergency department with fever. [editorial]. Ann Emerg Med 42 (2003) 546-549
5. Kupperman N. The evaluation of young febrile children for occult bacteremia: time to reevaluate our approach?. Arch Pediatr Adolesc Med 156 (2002) 855-857
6. Baraff L.J. Management of fever without source in infants and children. Ann Emerg Med 36 (2000) 602-614
7. Lee G.M., Fleisher G.R., and Harper M.B. Management of febrile children in the age of the conjugate pneumococcal vaccine: a cost-effectiveness analysis. Pediatrics 108 (2001) 835-844
8. Baraff L.J., Bass J.W., Fleisher G.R., et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without a source. Ann Emerg Med 22 (1993) 1198-1210
9. Bass J.W., Steele R.W., Witler R.R., et al. Antimicrobial treatment of occult bacteremia: a multicenter cooperative study. Pediatr Infect Dis 12 (1993) 466-473
10. Levine O.S., Fadey M., Harrison L.H., et al. Risk factors for invasive disease in children: a population-based case-control study in North America. Pediatrics 103 (1999) E28
11. Alpern E.R., Alessandrini E.A., Bell L.M., et al. Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome. Pediatrics 106 (2000) 505-511
12. Black S., Shinefield H., Fireman B., et al. Efficacy, safety, and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 19 (2000) 187-195
13. Black S.B., Shinefield H.R., Hansen J., et al. Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 20 (2001) 1105-1107
14. Herz A.M., Greenhow T.L., Alcantara J., et al. Changing epidemiology of outpatient bacteremia in the 3-36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine. Pediatr Infect Dis 25 (2006) 293-300
15. Hsaio A.L., Chen L., and Baker D. Incidence and predictors of serious bacterial infections among 57-180-day-old infants. Pediatrics 117 (2006) 1695-1701
16. Kornberg A.E., Jain N., and Dannenhoffer R. Evaluation of false positive blood cultures: guidelines for early detection of contaminated cultures in febrile children. Pediatr Emerg Care 10 (1994) 20-22
17. Gilbert E.H., Lowenstein S.R., Koziol-McLain J., et al. Chart reviews in emergency medicine research: where are the methods?. Ann Emerg Med 27 (1996) 305-308
18. Kayhty H., Ahman H., Eriksson K., et al. Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5, and 12 months of age. Pediatr Infect Dis J 24 (2005) 108-114
19. Nigrovic L.E., and Malley R. Evaluation of the febrile child 3 to 36 months old in the era of pneumococcal conjugate vaccine: focus on occult bacteremia. Clin Pediatr Emerg Med 5 (2004) 13-19
20. Kyaw M.H., Jones I.G., and Campbell H. Prevention of pneumococcal disease in children: pneumococcal conjugate vaccines: their use globally could have a major impact on public health. Acta Paediatr 90 (2001) 473-476
21. Stoll M.L., and Rubin L.G. Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine. Arch Pediatr Adolesc Med 158 (2004) 671-675
22. Dagan R., Givon-Lavi N., Zamir O., et al. Reduction of nasopharyngeal carriage of streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis 185 (2002) 927-936